There are two main objectives of this Core. First, we intend to provide training in the use of stable isotope technology within the BTRC for use by scientists and clinicians outside the BTRC. The goal is to expand the general knowledge of how to use stable isotopes for investigation of metabolic questions in intact tissues and patients. Much of the technology, once understood, is easily transferred to most university and medical school settings in the United States. Second, we intend to disseminate the results of the work described in the TR&D projects to the clinical and scientific community. The goal is to make physicians and biomedical scientists aware of the capabilities of the technologies and to encourage use of the advances from the BTRC. To achieve these goals, we propose four specific aims.
Aim 1 is to continue to present a two-day Annual Symposium with a focus on magnetic resonance and metabolism. The first day will be refocused on training in technology and the second day will continue to present broader biological and clinical topics that are relevant to the technology developed in the BTRC.
Aim 2 is to provide training tailored to the needs of visiting scientists, students, medical housestaff and subspeciality clinical fellows as necessary to allow investigators outside the BTRC to apply the technology to clinical problems.
Aim 3 is to disseminate results and technologies via multiple strategies including a continued local Mini-Symposium for Undergraduates, continued participation in the NIH Isotope Course presented by the NIDDK, a newly proposed training course in 13C isotopomer and flux analysis at the World Molecular Imaging Congress, the web page and teaching in graduate courses.
Aim 4 is to disseminate open source software designed for experiment planning, spectral analysis and metabolic fitting of 13C tracer experiments. Together, our training and dissemination activities provide a wide range of opportunities for investigators to learn to use stable isotopes for their studies in intermediary metabolism in patients and other systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Biotechnology Resource Grants (P41)
Project #
5P41EB015908-32
Application #
9850596
Study Section
Special Emphasis Panel (ZEB1)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Wu, Cheng-Yang; Satapati, Santhosh; Gui, Wenjun et al. (2018) A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity. J Biol Chem 293:9604-9613
Ren, Jimin; Shang, Ty; Sherry, A Dean et al. (2018) Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T. Magn Reson Med 80:1289-1297
Burnett, Marianne E; Adebesin, Bukola; Ratnakar, S James et al. (2018) Crystallographic Characterization and Non-Innocent Redox Activity of the Glycine Modified DOTA Scaffold and Its Impact on EuIII Electrochemistry. Eur J Inorg Chem 2018:1556-1562
Cui, Jiaming; Dimitrov, Ivan E; Cheshkov, Sergey et al. (2018) An Adjustable-Length Dipole Using Forced-Current Excitation for 7T MR. IEEE Trans Biomed Eng 65:2259-2266
Sirusi, Ali A; Suh, Eul Hyun; Kovacs, Zoltan et al. (2018) The effect of Ho3+ doping on 13C dynamic nuclear polarization at 5 T. Phys Chem Chem Phys 20:728-731
Courtney, Kevin D; Bezwada, Divya; Mashimo, Tomoyuki et al. (2018) Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. Cell Metab 28:793-800.e2
Potts, Austin; Uchida, Aki; Deja, Stanislaw et al. (2018) Cytosolic phosphoenolpyruvate carboxykinase as a cataplerotic pathway in the small intestine. Am J Physiol Gastrointest Liver Physiol 315:G249-G258
Wu, Cheng-Yang; Tso, Shih-Chia; Chuang, Jacinta L et al. (2018) Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice. Mol Metab 12:12-24
Jin, Eunsook S; Browning, Jeffrey D; Murphy, Rebecca E et al. (2018) Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans. J Lipid Res 59:1685-1694
Makarewich, Catherine A; Baskin, Kedryn K; Munir, Amir Z et al. (2018) MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid ?-Oxidation. Cell Rep 23:3701-3709

Showing the most recent 10 out of 149 publications